Revolution Medicines Develops New Oral Treatment for Rare Disease
The United States Food and Drug Administration (FDA) has approved Rasonque, an oral tablet developed by American biotechnology firm Revolution Medicines, offering a targeted new therapeutic option for patients diagnosed … Read More